Macroeconomic Monitor
Home / Tags: drug policy (page 2)

drug policy

Reform for more accessible and cheaper medicines in Bulgaria

cheap drugs

|Full text of the analysis| Summary and conclusions from the analysis of the sartan group: The results of this study confirm the conclusions of previous analyses, such as the World Bank's 2015 analysis, as well as good practices from EU countries, and quantify the positive effects of implementing a progeneric policy within the framework of …

More »

Is our drug policy economically effective?

drug policy

What is the problem with medicines? The problems in Bulgarian healthcare are not only with medicines. The problem of the entire system is actually the inefficient spending of funds, which is getting worse every year. The second problem is that since the establishment of the National Health Insurance Fund (NHIF) until today, its budget has been growing by an average of about 7% per …

More »

Cheaper drugs? Why not?!

As we have already understood, the budget of the National Health Insurance Fund (NHIF) grows annually and unjustifiably. On the other hand, mortality is increasing, while diseases are showing a constant trend. Theft through referrals has been a known fact for years and is easily noticeable in regional statistics. Since we have begun to dismantle the healthcare system, we must …

More »